4-Cyano-4′-n-undecylbiphenyl, C24N1H31 M r ' 333.52, triclinic, P1, a ' 9.755(2), b ' 11.322(1), c ' 19.911(2)Å, α '96.86(1), β ' 94.41(2), γ ' 109.16(1)˚, V ' 2046.46 Å, Z ' 4, Dx ' 1.082 g/cc, μ ' 0.574 cm−1, F(000) ' 728.0, λ(MoKα) ' 0.71073 Å, T ' 326 K, final R and wR are 0.0476 and 0.0625 respectively for 7225 reflections included in least squares calculations.
No takes yet. Share an insight, caveat, or question.
Manisekaran et al. (1995) studied this question.
Synapse has enriched 2 closely related papers on similar clinical questions. Consider them for comparative context: